Awards GeekWire Awards: Health Innovation of the Year Field Is Dominated by Finalists Battling CancerGeekWire | March 24, 2025The GeekWire Awards finalists for Health Innovation of the Year are dominated by ventures that…karnottMarch 24, 2025 Read More
Local News Brainy Fun for All Ages at BrainFest 2025Allen Institute | March 21, 2025Have you ever wondered how you wonder? On March 15, 2025, crowds of curious families,…karnottMarch 21, 2025 Read More
Local News Scientists Create Method for Designing Proteins That Can Bind and Sense a Range of Small MoleculesPhys Org | March 20, 2025From growth hormones to cancer drugs, small molecules play a crucial role in our health.…karnottMarch 20, 2025 Read More
Local News World’s First Crowd-Sourced Neuroscience Study Aims To Understand How Our Brains Predict the FutureAllen Institute | March 20, 2025An international collaboration of over 50 neuroscientists and researchers is pioneering a new approach to…karnottMarch 20, 2025 Read More
Local News Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell LymphomaAdaptive Biotechnologies | March 19, 2025Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the…karnottMarch 19, 2025 Read More
Local News Prostate Cancer Is Not a Death Knell, Study ShowsUW Medicine | March 19, 2025Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases…karnottMarch 19, 2025 Read More
Local News Looking Back on UW Innovations After Five Years of COVID-19University of Washington Magazine | March 19, 2025Five years ago this winter, the University of Washington became a leader in the local…karnottMarch 19, 2025 Read More
Awards Newborn Jaundice Detection Tool Wins Grand Prize at UW Health Innovation ChallengeGeekWire | March 18, 2025A trio of students from the University of Washington won the grand prize at the…karnottMarch 18, 2025 Read More
Publications of the Week Safety and Efficacy of Acalabrutinib Plus Bendamustine and Rituximab in Patients With Treatment-Naïve or Relapsed/Refractory Mantle Cell Lymphoma: Phase Ib TrialPhillips, T., et al. | March 18, 2025This multicenter, open-label, phase Ib study (ACE-LY-106) assessed the safety and efficacy of acalabrutinib, bendamustine,…karnottMarch 18, 2025 Read More
Awards Steven Kahn Receives Banting Medal for Scientific AchievementUW Medicine | March 17, 2025Dr. Steven Kahn , professor (Metabolism, Endocrinology and Nutrition) is the 2025 recipient of the…karnottMarch 17, 2025 Read More